Abstract
Purpose of Review
We herein address the most up-to-date findings in the literature in relation to surgical and non-surgical organ preservation strategies aimed at treatment of T3 laryngeal cancer.
Recent Findings
T3 laryngeal cancer represents an advanced stage of neoplastic lesions that poses significant challenges in terms of oncologic outcomes as well as function preservation. In the present form of the TNM staging system, T3 of the larynx includes a wide range of different neoplasms that spread into the visceral (paraglottic and pre-epiglottic) spaces of the organ or tend to infiltrate its cartilaginous framework. A number of therapeutic tools are available for its management and include transoral laser microsurgery, open-neck partial laryngectomies, non-surgical organ preservation strategies (mainly in the form of concurrent chemoradiation), and total laryngectomy with/without complementary (chemo)-radiotherapy according to the postoperative histopathologic evaluation of the surgical specimen.
Summary
No prospective randomized controlled trial has been performed to compare the different options in terms of oncologic and functional outcomes due to the multiple tumor and patient-related variables that should ideally be taken into account. Therefore, lacking precise evidence-based data, the choice among the different therapeutic alternatives, even in the presence of a multidisciplinary head and neck cancer team, is mainly made on the basis of institutional and cultural preferences.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Sobin LH, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours. 7th ed. Oxford: Wiley-Blackwell; 2010.
McMullen CP, Smith RV. Treatment/comparative therapeutics: cancer of the larynx and hypopharynx. Surg Oncol Clin N Am. 2015;24:521–45.
Breda E, Catarino R, Monteiro E. Transoral laser microsurgery for laryngeal carcinoma: survival analysis in a hospital-based population. Head Neck. 2015;37:1181–6.
Hakeem AH, Tubachi J, Pradhan SA. Significance of anterior commissure involvement in early glottic squamous cell carcinoma treated with transoral CO2 laser microsurgery. Laryngoscope. 2013;123:1912–7.
Lee HS, Chun BG, Kim SW, et al. Transoral laser microsurgery for early glottic cancer as one-stage single-modality therapy. Laryngoscope. 2013;123:2670–4.
•• Pantazis D, Liapi G, Kostarelos D, et al. Glottic and supraglottic pT3 squamous cell carcinoma: outcomes with transoral laser microsurgery. Eur Arch Otorhinolaryngol. 2015;272:1983–90. The Authors describe different 5-year disease-specific survivals and organ preservation rates obtained by TLM in supraglottic (both 91.7%) and glottic pT3 (63.2% and 73.3%, respectively). This underlines the presence of possible stratifications within “good” and “bad” supraglottic T3, while such a category in glottic lesions should be always regarded as a suboptimal clinical scenario for TLM
Mendelsohn AH, Kiagiadaki D, Lawson G, et al. CO2 laser cordectomy for glottic squamous cell carcinoma involving the anterior commissure: voice and oncologic outcomes. Eur Arch Otorhinolaryngol. 2015;272:413–8.
Garofolo S, Piazza C, Del Bon F, et al. Intraoperative narrow band imaging better delineates superficial resection margins during transoral laser microsurgery for early glottic cancer. Ann Otol Rhinol Laryngol. 2015;124:294–8.
Peretti G, Plazza C, Cocco D, et al. Transoral CO2 laser treatment for tis-T3 glottic cancer: the Brescia experience on 595 patients. Head Neck. 2010;32:977–83.
Hoffmann C, Hans S, Sadoughi B, et al. Identifying outcome predictors of transoral laser cordectomy for early glottic cancer. Head Neck. 2016;38(Suppl 1):E406–11.
•• Canis M, Ihler F, Martin A, et al. Results of 226 patients with T3 laryngeal carcinoma after treatment with transoral laser microsurgery. Head Neck. 2014;36:652–9. One of the largest series in the literature of T3 laryngeal tumors treated by TLM, describing the oncologic outcomes obtained by such a therapeutic tool and its inherent limitations
Canis M, Martin A, Ihler F, et al. Transoral laser microsurgery in treatment of pT2 and pT3 glottic laryngeal squamous cell carcinoma - results of 391 patients. Head Neck. 2014;36:859–66.
Vilaseca I, Bernal-Sprekelsen M, Him R, et al. Prognostic factors of quality of life after transoral laser microsurgery for laryngeal cancer. Eur Arch Otorhinolaryngol. 2015;272:1203–10.
Wilkie MD, Lightbody KA, Lythgoe D, et al. Transoral laser microsurgery for early and moderately advanced laryngeal cancers: outcomes from a single centralised United Kingdom centre. Eur Arch Otorhinolaryngol. 2015;272:695–704.
Peretti G, Piazza C, Mora F, et al. Reasonable limits for transoral laser microsurgery in laryngeal cancer. Curr Opin Otolaryngol Head Neck Surg. 2016;24:135–9.
•• Piazza C, Mangili S, Bon FD, et al. Preoperative clinical predictors of difficult laryngeal exposure for microlaryngoscopy: the Laryngoscore. Laryngoscope. 2014;124:2561–7. The Authors describe an easy and reproducible preoperative assessment protocol (the Laryngoscore) including 11 parameters to predict difficult laryngeal exposure during operative microlaryngoscopy. When the score was <6 favourable laryngeal exposure was observed in 94% of patients. For scores >6 and >9, difficult or impossibile laryngeal exposures were observed in 40% and 67% of patients, respectively
Mizrachi A, Rabinovics N, Hilly O, et al. Analysis of failure following transoral laser surgery for early glottic cancer. Eur Arch Otorhinolaryngol. 2014;271:2247–51.
Succo G, Peretti G, Piazza C, et al. Open partial horizontal laryngectomies: a proposal for classification by the working committee on nomenclature of the European laryngological society. Eur Arch Otorhinolaryngol. 2014;271:2489–96.
Sixteenth BE, Daniel C. Baker, Jr, memorial lecture. Surgical management of supraglottic cancer and its lymph node metastases in a conservative perspective. Ann Otol Rhinol Laryngol. 1991;100:261–7.
Isaacs JH Jr, Slattery WH 3rd, Mendenhall WM, et al. Supraglottic laryngectomy. Am J Otolaryngol. 1998;19:118–23.
•• Vilaseca I, Bernal-Sprekelsen M, Blanch JL. Transoral laser microsurgery for T3 laryngeal tumors: prognostic factors. Head Neck. 2010;32:929–38. Critical reappraisal of the most limiting factors for adequate management of laryngeal T3 by a transoral approach
Rioja E, Blanch JL, Borés A, et al. Clinical significance of granulation tissue after transoral laser microsurgery for glottic cancer. J Laryngol Otol. 2015;129:377–82.
• Peretti G, Piazza C, Penco S, et al. Transoral laser microsurgery as primary treatment for selected T3 glottic and supraglottic cancers. Head Neck. 2016;38:1107–12. Oncologic outcomes obtained by TLM in T3 glottic and supraglottic tumors following a more “conservative” philosophy than that described by other authors in the literature
Chevalier D, Laccourreye O, Brasnu D, et al. Cricohyoidoepiglottopexy for glottic carcinoma with fixation or impaired motion of the true vocal cord: 5-year oncologic results with 112 patients. Ann Otol Rhinol Laryngol. 1997;106:364–9.
Laccourreye O, Brasnu D, Biacabe B, et al. Neo-adjuvant chemotherapy and supracricoid partial laryngectomy with cricohyoidopexy for advanced endolaryngeal carcinoma classified as T3-T4: 5-year oncologic results. Head Neck. 1998;20:595–9.
Gallo A, Manciocco V, Simonelli M, et al. Supracricoid partial laryngectomy in the treatment of laryngeal cancer: univariate and multivariate analysis of prognostic factors. Arch Otolaryngol Head Neck Surg. 2005;131:620–5.
Laudadio P, Presutti L, Dall’olio D, et al. Supracricoid laryngectomies: long-term oncological and functional results. Acta Otorhinolaryngol. 2006;126:640–9.
• Rizzotto G, Crosetti E, Lucioni M, et al. Oncologic outcomes of supratracheal laryngectomy: critical analysis. Head Neck. 2015;37:1417–24. Oncologic outcomes of an innovative “extreme” form of open partial laryngectomy as a conservative surgical alternative to total laryngectomy
•• Succo G, Crosetti E, Bertolin A, et al. Benefits and drawbacks of open partial horizontal laryngectomies, part B: intermediate and selected advanced stage laryngeal carcinoma. Head Neck. 2016;38(Suppl 1):E649–57. Oncologic outcomes in one of the largest series in the literature of open partial laryngectomies, focusing on T3-T4 laryngeal tumors
The Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med. 1991;324:1685–90.
Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med. 2003;349:2091–8.
Forastiere AA, Zhang Q, Weber RS, et al. Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer. J Clin Oncol. 2013;31:845–52.
Timme DW, Jonnalagadda S, Patel R, et al. Treatment selection for T3/T4a laryngeal cancer: chemoradiation versus primary surgery. Ann Otol Rhinol Laryngol. 2015;124:845–51.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Dr. Cesare Piazza and Dr. Alberto Paderno declare that they have no conflicts of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical Collection on Head and Neck: Laryngeal Cancer
Rights and permissions
About this article
Cite this article
Piazza, C., Paderno, A. Conservative Surgical and Non-surgical Options in Management of T3 Laryngeal Cancer. Curr Otorhinolaryngol Rep 5, 125–131 (2017). https://doi.org/10.1007/s40136-017-0155-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40136-017-0155-3